NCT03308591View on ClinicalTrials.gov

Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

774

Participants

Timeline

Start Date

January 11, 2016

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Uterine Cervical NeoplasmCervical CancerUterine Cervical Cancer
Interventions
DRUG

NACT

Platin based chemotherapy

PROCEDURE

RT+PLND

radical hysterectomy+pelvic lymphadenectomy

DRUG

Adjuvant chemotherapy

Platin based chemotherapy

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Huazhong University of Science and Technology

OTHER

NCT03308591 - Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients | Biotech Hunter | Biotech Hunter